A detailed history of Park Avenue Securities LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Park Avenue Securities LLC holds 42,854 shares of BMY stock, worth $2.41 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,854
Previous 44,443 3.58%
Holding current value
$2.41 Million
Previous $1.85 Million 20.1%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$39.66 - $51.75 $63,019 - $82,230
-1,589 Reduced 3.58%
42,854 $2.22 Million
Q2 2024

Jul 09, 2024

SELL
$40.25 - $52.99 $324,737 - $427,523
-8,068 Reduced 15.36%
44,443 $1.85 Million
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $593,176 - $672,547
12,363 Added 30.79%
52,511 $2.85 Million
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $516,408 - $616,218
-10,652 Reduced 20.97%
40,148 $2.06 Million
Q3 2023

Oct 26, 2023

BUY
$57.89 - $64.73 $61,537 - $68,807
1,063 Added 2.14%
50,800 $2.95 Million
Q2 2023

Jul 14, 2023

SELL
$63.71 - $70.74 $395,002 - $438,587
-6,200 Reduced 11.08%
49,737 $3.18 Million
Q1 2023

Apr 18, 2023

BUY
$65.71 - $74.53 $679,638 - $770,863
10,343 Added 22.69%
55,937 $3.88 Million
Q4 2022

Jan 24, 2023

BUY
$68.48 - $81.09 $597,761 - $707,834
8,729 Added 23.68%
45,594 $0
Q3 2022

Nov 01, 2022

BUY
$0.13 - $76.84 $295 - $174,657
2,273 Added 6.57%
36,865 $2.62 Million
Q2 2022

Jul 27, 2022

BUY
$72.62 - $79.98 $109,365 - $120,449
1,506 Added 4.55%
34,592 $2.66 Million
Q1 2022

Apr 29, 2022

BUY
$61.48 - $73.72 $804,035 - $964,110
13,078 Added 65.36%
33,086 $2.42 Million
Q4 2021

Apr 08, 2022

BUY
$53.63 - $62.52 $177,783 - $207,253
3,315 Added 19.86%
20,008 $1.25 Million
Q3 2021

Oct 21, 2021

SELL
$59.17 - $69.31 $382,711 - $448,297
-6,468 Reduced 27.93%
16,693 $988,000
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $472,001 - $514,010
-7,624 Reduced 24.77%
23,161 $1.55 Million
Q1 2021

Apr 28, 2021

SELL
$59.34 - $66.74 $215,107 - $241,932
-3,625 Reduced 10.53%
30,785 $1.94 Million
Q4 2020

Jan 20, 2021

BUY
$57.74 - $65.43 $92,384 - $104,688
1,600 Added 4.88%
34,410 $2.13 Million
Q3 2020

Nov 03, 2020

BUY
$57.43 - $63.64 $129,906 - $143,953
2,262 Added 7.4%
32,810 $1.98 Million
Q2 2020

Jul 30, 2020

BUY
$54.82 - $64.09 $1.67 Million - $1.96 Million
30,548 New
30,548 $1.8 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $819,702 - $1.19 Million
-17,666 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $214,506 - $279,804
4,359 Added 32.76%
17,666 $1.13 Million
Q3 2019

Oct 18, 2019

BUY
$42.77 - $50.71 $569,140 - $674,797
13,307 New
13,307 $675,000
Q2 2019

Jul 26, 2019

SELL
$44.62 - $49.34 $464,404 - $513,530
-10,408 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$45.12 - $53.8 $469,608 - $559,950
10,408 New
10,408 $490,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.